Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
ABL Inc
ABL Inc
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Advanced Biological Laboratories reaches milestone for COVID-19 assay
ABL has received CE-IVD Registration for its UltraGene Combo2Screen SARS-CoV-2 Assay
Containment
ABL acquires former Accinov GMP manufacturing plant
The US biotech CDMO now operates a 6,500sqm facility in Lyon equipped with grade B and C cleanrooms and self-contained labs
Manufacturing
Sartorius supports ABL Europe to expand viral vector GMP capacity
A global technology player in the biopharma industry supports a supplier of viral vector manufacturing services to successfully complete a capacity expansion
Finance
Transgene sells biopharmaceutical manufacturing facility to ABL Europe
Also signs a three-year deal with ABL Europe to produce clinical lots of immunotherapies under development for cancer and infectious diseases
Subscribe now